WallStreetZenWallStreetZen

NASDAQ: SYRS
Syros Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SYRS

Based on 2 analysts offering 12 month price targets for Syros Pharmaceuticals Inc.
Min Forecast
$13.00+154.9%
Avg Forecast
$14.00+174.51%
Max Forecast
$15.00+194.12%

Should I buy or sell SYRS stock?

Based on 2 analysts offering ratings for Syros Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SYRS stock forecasts and price targets.

SYRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-04-01

1 of 1

Forecast return on equity

Is SYRS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is SYRS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SYRS revenue forecast

What is SYRS's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M-49.68%
Avg 2 year Forecast
$67.7M+581.36%
Avg 3 year Forecast
$184.3M+1,754.37%
SYRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SYRS revenue growth forecast

How is SYRS forecast to perform vs Biotechnology companies and vs the US market?
Company
160.95%
Industry
37.04%
Market
9.92%
SYRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SYRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SYRS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SYRS$5.10$14.00+174.51%Strong Buy
DBVT$0.69$10.00+1,351.38%Buy
RPTX$3.15$10.00+217.46%Buy
CLLS$2.49$6.00+140.96%Buy
TVGN$0.85N/AN/A
View Top Biotech Stocks

Syros Pharmaceuticals Stock Forecast FAQ

Is Syros Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SYRS) stock is to Strong Buy SYRS stock.

Out of 2 analysts, 1 (50%) are recommending SYRS as a Strong Buy, 1 (50%) are recommending SYRS as a Buy, 0 (0%) are recommending SYRS as a Hold, 0 (0%) are recommending SYRS as a Sell, and 0 (0%) are recommending SYRS as a Strong Sell.

If you're new to stock investing, here's how to buy Syros Pharmaceuticals stock.

What is SYRS's revenue growth forecast for 2024-2026?

(NASDAQ: SYRS) Syros Pharmaceuticals's forecast annual revenue growth rate of 160.95% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Syros Pharmaceuticals's revenue in 2024 is $9,936,000.On average, 1 Wall Street analysts forecast SYRS's revenue for 2024 to be $132,269,455, with the lowest SYRS revenue forecast at $132,269,455, and the highest SYRS revenue forecast at $132,269,455. On average, 2 Wall Street analysts forecast SYRS's revenue for 2025 to be $1,790,928,421, with the lowest SYRS revenue forecast at $132,269,455, and the highest SYRS revenue forecast at $3,449,587,386.

In 2026, SYRS is forecast to generate $4,874,129,417 in revenue, with the lowest revenue forecast at $1,039,637,916 and the highest revenue forecast at $8,708,620,917.

What is SYRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SYRS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SYRS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SYRS price target, the average SYRS price target is $14.00, with the highest SYRS stock price forecast at $15.00 and the lowest SYRS stock price forecast at $13.00.

On average, Wall Street analysts predict that Syros Pharmaceuticals's share price could reach $14.00 by Apr 3, 2025. The average Syros Pharmaceuticals stock price prediction forecasts a potential upside of 174.51% from the current SYRS share price of $5.10.

What is SYRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SYRS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.